Neurosurgery

Professional Education
Alzheimer's 8: Dementia Update for PCPs: Disease-Modifying Medications Risks and Benefits
A panel of dementia specialists provide up-to-date information on new disease-modifying medications receiving FDA approval, but with specific candidate criteria. Practitioners will learn how these medications work, which of their patients may benefit, how to identify and address risks, and how to effectively communicate with patients and family members. [1.50 AMA PRA Category 1 Credits™, 1.50 Contact Hours (ANCC)]
1.5 credits

Feb 21, 2024
Identifying Malpractice Risks for Surgical Practices
Julie Brightwell, JD, RN, Director, Healthcare Systems Patient Safety, The Doctors Company, Part of TDC Group
Understanding that the causes of claims are multifactorial and rarely result from individual judgment or technical skill alone can help surgeons improve outcomes.

Jan 03, 2024
Healthcare Practitioners and On-Call Duties: Top Questions on Liability Risks
Richard F. Cahill, JD, Vice President and Associate General Counsel, The Doctors Company
Our experts respond to questions about medical staff bylaws and on-call service requirements.

Oct 24, 2022
Why Medical Clearance Is Really a Preoperative Evaluation
Debra Davidson, MJ, CPHRM, Senior Patient Safety Risk Manager, The Doctors Company, and David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group; Senior Vice President, Healthcare Risk Advisors
The goals of the preoperative evaluation are to determine the patient's level of risk and to identify opportunities to mitigate it.

Mar 01, 2022
With Medical Implants, Hope and Plan for the Best, but Talk About the Worst
David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group; Senior Vice President, Healthcare Risk Advisors
Even with common implant procedures, variability among human systems creates risks and uncertainties. Dr. David L. Feldman discusses the importance of a true informed consent process using shared decision making.
From The Doctor’s Advocate

Nov 29, 2021
The Evolving Landscape of Diagnostic Errors—Challenges and Opportunities
David E. Newman-Toker, MD, PhD, Professor of Neurology, Ophthalmology, and Otolaryngology, and Director, Armstrong Institute Center for Diagnostic Excellence, Johns Hopkins University School of Medicine
Internationally recognized healthcare leader David E. Newman-Toker, MD, PhD, presents a compelling case example and shares key insights into transforming diagnostic accuracy.
From The Doctor’s Advocate

Aug 06, 2021
The Malpractice Experience of Neurosurgeons 2014–2019: Patient Selection and Communication May Mitigate Risk of Claims (Abstract)
Jacqueline Ross, RN, PhD, Coding Director, Department of Patient Safety and Risk Management
The Doctors Company conducted an analysis of medical malpractice claims against neurosurgeons that closed between the years of 2014 and 2019. This evaluation included 302 claims and lawsuits, and examined allegations, diagnoses, procedures, and contributing factors, as well as indemnities and expenses paid. The claims experience of neurosurgeon members of The Doctors Company was then benchmarked against a national sample of other neurosurgeons.